Insiders bought 14K on the open market and sold nothing.
Get an email when TXMD's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Tommy G Thompson Director | Bought | 8,400 | $1.67 | 14K | 29% | Form 4 |
| Apr 14, 2025 | Tommy G Thompson Director | Bought | 325 | $1.00 | $325 | 1.1% | Form 4 |
| Apr 14, 2025 | Marlan D Walker Chief Executive Officer | Bought | 490 | $1.00 | $490 | 0.7% | Form 4 |
| Apr 9, 2025 – Apr 10, 2025 | Marlan D Walker Chief Executive Officer | Bought 2 parts | 2,303 | $0.86 average | 2K | 3.3% | Form 4 |
- Dec 23, 2025Tommy G ThompsonDirector · bought 8,400 at $1.6714K29% of stake
- Apr 14, 2025Tommy G ThompsonDirector · bought 325 at $1.00$3251.1% of stake
- Apr 14, 2025Marlan D WalkerChief Executive Officer · bought 490 at $1.00$4900.7% of stake
- Apr 9, 2025 – Apr 10, 2025Marlan D WalkerChief Executive Officer · bought 2,303 at avg $0.862K3.3% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with TXMD
Spot a number that looks wrong? Check it in TXMD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing TXMD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.